Serveur d'exploration sur l'Indium - Corpus (Accueil)

Index « Auteurs » - entrée « P Angelberger »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P Andersson < P Angelberger < P Antoniw  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
003693 (2002) Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
003842 (2001) Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
003850 (2001) Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.
003958 (2001) New trends in peptide receptor radioligands.
003A83 (2001) Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
003C26 (2000) New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
003D25 (2000) Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
003D67 (1999) "MAURITIUS": tumour dose in patients with advanced carcinoma.
003E05 (1999) DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
003F97 (1998) Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.
004016 (1998) Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
004018 (1998) Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
004063 (1998) Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
004532 (1996) In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
004575 (1996) Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
004669 (1996) Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
004C34 (1994) Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia.
005024 (1993) Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.
005274 (1992) Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.
005484 (1991) Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein.
005749 (1991) Recent developments in receptor binding radiopharmaceuticals.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/Author.i -k "P Angelberger" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/Author.i  \
                -Sk "P Angelberger" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    P Angelberger
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024